Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and stress-predominant mixed incontinence.
about
The efficacy and safety of urethral injection therapy for urinary incontinence in women: a systematic reviewPeriurethral bulking agents for female stress urinary incontinence in Canada.Female urinary stress incontinence.Efficacy of dextranomer hyaluronic acid and polyacrylamide hydrogel in endoscopic treatment of vesicoureteral reflux: A comparative study.Urolastic for the treatment of women with stress urinary incontinence: 24-month follow-up.Durability, safety and efficacy of polyacrylamide hydrogel (Bulkamid(®)) in the management of stress and mixed urinary incontinence: three year follow up outcomes.Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents.Mixed urinary incontinence: international urogynecological association research and development committee opinion.Mixed incontinence: what takes precedence in its management?Polyacrylamide hydrogel (Bulkamid®) for stress urinary incontinence in women: a systematic review of the literature.A national population-based cohort study of urethral injection therapy for female stress and mixed urinary incontinence: the Danish Urogynaecological Database, 2007-2011.Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome?Urethral bulking for recurrent stress urinary incontinence after midurethral sling failure.Use of periurethral injections of polyacrylamide hydrogel for treating post-vesicovaginal fistula closure urinary stress incontinence.Long-term follow-up after urethral injection with polyacrylamide hydrogel for female stress incontinence.Transanal submucosal polyacrylamide gel injection treatment of anal incontinence: a randomized controlled trial.Outpatient periurethral injections of polyacrylamide hydrogel for the treatment of female stress urinary incontinence: effectiveness and safety.Treatment of Vesicovaginal Fistulas With Autologous Cell Injections—A Randomized Study in an Animal Model.Re:Urethral bulking for recurrent stress urinary incontinence after midurethral sling failure.
P2860
Q28080054-DAE9A0AE-350D-4E8E-A6AF-C110A74C539BQ33769908-0C086CED-B138-4A7B-9DA3-92BB317CEB15Q35772324-998E2B98-0567-4712-930F-8EFEF74801CEQ35777560-28FF5EF6-FD52-4C06-9F0C-149EF7FB138FQ36276749-DFA790C6-6BCA-4830-9FC1-857093DD245AQ36547500-3AE22C02-F96B-402E-A63B-D5FBD94BD4D5Q38065956-E788B6CE-7776-45D1-BAD0-90F967D36E9DQ38236932-845A2C08-1BA8-4195-BF0D-7DC91343548FQ38257166-449371FC-FA63-4450-96A6-3C3999AE44F2Q38554008-EB0BCB6D-E7DC-4133-AF79-1839FA11D073Q38955974-0FD94CF2-AC72-481E-B6D6-C68C2F42457CQ39156895-A8CA663D-59FB-4B2C-A7EA-91CF4E8E95DCQ40731394-0B4B15C1-3FD7-455A-AB61-68F079704C1BQ44652225-335E78DA-F456-4E73-8E6B-6AFDFE13FE3FQ46286052-5F4ED59A-7B77-4339-A26F-5F84C4F4ACA1Q47828704-79ED367A-D61B-4097-A733-B57A467FCB86Q48306544-C637AB97-230E-49E5-9720-4559F659EB16Q49228360-A73A2067-5B27-47C0-875A-89BB9CDFA952Q50877778-3EC818C4-3E2C-440E-A2E0-0FFA78C6D743
P2860
Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and stress-predominant mixed incontinence.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Two-year follow-up of an open- ...... redominant mixed incontinence.
@ast
Two-year follow-up of an open- ...... redominant mixed incontinence.
@en
type
label
Two-year follow-up of an open- ...... redominant mixed incontinence.
@ast
Two-year follow-up of an open- ...... redominant mixed incontinence.
@en
prefLabel
Two-year follow-up of an open- ...... redominant mixed incontinence.
@ast
Two-year follow-up of an open- ...... redominant mixed incontinence.
@en
P2093
P2860
P1476
Two-year follow-up of an open- ...... predominant mixed incontinence
@en
P2093
Gunilla Tegerstedt
Gunnar Lose
Michelle Fynes
Waleed Al-Singary
P2860
P2888
P304
P356
10.1007/S00192-012-1761-8
P577
2012-04-25T00:00:00Z